Key result
AI decision support cuts 12-month major CV events ~20% in women with suspected ACS.
Why the study?
Women presenting to the ED with suspected ACS face higher misdiagnosis and adverse outcome rates, and existing decision aids have sex-specific limitations. While point-of-care AI-based clinical decision support may reduce this inequity, its real-world impact on sex-based disparities remained uncertain.
Does real-time AI-based clinical decision support reduce 12-month cardiovascular death, myocardial infarction, and unplanned cardiovascular readmission in women presenting to the emergency department with suspected acute coronary syndrome?
RCT (n=14,131)
Cluster-randomised
Yes
Does real-time AI-based clinical decision support reduce 12-month cardiovascular death, myocardial infarction, and unplanned cardiovascular readmission in women presenting to the emergency department with suspected acute coronary syndrome?
Real-time AI-based clinical decision support in the emergency department significantly reduced 12-month major cardiovascular events in women presenting with suspected cardiac chest pain, particularly those at higher baseline risk, offering a potential strategy to mitigate sex-based disparities in acute coronary syndrome care.
Answers are grounded in this paper and cite their sources.
AI decision support reduces 12-month CV events; extends RCT evidence for AI integration in cardiology workflows.
Background Women presenting to the emergency department (ED) with suspected acute coronary syndrome (ACS) experience higher rates of misdiagnosis and adverse outcomes than men. Existing clinical decision aids improve risk stratification but have sex-specific limitations that may disadvantage women. Artificial intelligence (AI)-based clinical decision support at the point of care has the potential to reduce this inequity, though its real-world impact remains uncertain. Purpose To determine whether AI-based decision support narrows sex-based disparities in care and outcomes among patients with suspected cardiac chest pain. Methods We conducted a sex-specific subgroup analysis of a multicentre cluster-randomised controlled trial across 12 South Australian EDs which deployed real-time AI-based clinical decision support in the ED for suspected ACS. Analyses were conducted both on the overall cohort, and among those with a predicted 30-day risk of death or myocardial infarction (MI) of >1%. The primary outcome was 12-month cardiovascular (CV) death, MI and unplanned CV readmission. Time-to-event outcomes were analysed with Cox proportional hazards models, adjusted for clustering. Results Among 14,131 participants (49% women), AI-based decision support reduced the 12-month primary composite endpoint in women (HR 0.80, 95% CI 0.70-0.92; p = 0.001), with the greatest effect in the elevated-risk group (HR 0.76, 95% CI 0.69–0.85; p < 0.001). No significant benefit was observed in men, suggesting that the intervention did not impact the cohort uniformly. Conclusion AI-based decision support reduced major CV events in women presenting to the ED with suspected cardiac chest pain, with effects most evident in those at higher baseline risk. This may represent a novel strategy to address sex-based inequities in ACS care.
No takes yet. Share an insight, caveat, or question.
Rebecca et al. (2026) conducted an RCT in Suspected acute coronary syndrome / cardiac chest pain (n=14,131). Real-time AI-based clinical decision support was evaluated on 12-month cardiovascular death, myocardial infarction, and unplanned cardiovascular readmission (HR 0.80, 95% CI 0.70-0.92, p=0.001). AI-based clinical decision support reduced 12-month CV death, MI, and unplanned CV readmission in women with suspected ACS, with no significant benefit in men.
Synapse has enriched 10 related papers. Consider them for comparative context: